Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2012-04-04
Original SEC Filing: Click here

---

Webplus: BSPM/20120404/8-K_1/2_EX-3.1/000.htm SEC Original: ex3-1.htm
ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF BIOSTAR PHARMACEUTICALS, INC. This is to certify that: FIRST SECOND THIRD FOURTH IN WITNESS WHEREOF Biostar Pharmaceuticals, Inc. Ronghua Wang Shuang Gong Chief Executive Officer Secretary EX-3.1 2 ex3-1.htm

---

---

Webplus: BSPM/20120404/8-K_1/3_EX-99.1/000.htm SEC Original: ex99-1.htm
BIOSTAR PHARMACEUTICALS TO EFFECT REVERSE STOCK SPLIT — XIANYANG, China, April 3, 2012 As a result of the reverse stock split, the number of outstanding common shares will be reduced to approximately 9,398,892. Fractional stockholdings will be rounded up to the nearest whole number. The reverse stock split will affect all stockholders uniformly and will not affect any stockholder’s ownership

---

---

Webplus: BSPM/20120404/8-K_1/1/000.htm SEC Original: biostar8k040312.htm
FORM 8-K CURRENT REPORT April 3, 2012 Date of Report (Date of earliest event reported): BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Xi Avenue Xianyang City, Shaanxi Province People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2012-04-04CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046